A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants
Lang ML, Hall RT, Reddy NS, Kurth CG, Merritt TA. A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants. J Pediatr 1990; 116: 295-300.
Multicenter trial of single-dose modified bovine surfactant extract (survanta) for prevention of respiratory distress syndrome
Soll RF, Hoekstra RE, Fangman JJ, Corbet AJ, Adams JM, James LS, et al. Multicenter trial of single-dose modified bovine surfactant extract (survanta) for prevention of respiratory distress syndrome. Pediatrics 1990; 85: 1092-102.
Initial clinical trial of exosurf, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease
Phibbs RH, Ballard RA, Clements JA, Heilbron DC, Phibbs CS, Schlueter MA, et al. Initial clinical trial of exosurf, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease. Pediatrics 1991; 88: 1-9.
Pharmacopoeia Committee of People's Republic of China. Pharmacopoeia of People's Republic of China. Beijing: Chemical Industry Press, 1990: Appendix. 106.
Pulmonary effects after surfactant treatment in premature infants with severe respiratory distress syndrome
Farstad T, Bratlid D. Pulmonary effects after surfactant treatment in premature infants with severe respiratory distress syndrome. Biol Neonate 1995; 68: 246-53.